100% Locally Owned, Independent and Free

100% Locally Owned, Independent and Free

University to head trials for 'three-in-one' investigational vaccine

Do you have a news tip? Click here to send to our news team.

Robert Irwin named Queensland Australian of the Year

A wildlife conservationist and an advocate for people with disability from the Sunshine Coast are among the people named as Queensland's Australian of the More

Buyers offered rare dual-penthouse opportunity

Two adjoining penthouses held by the same family for about 20 years could change hands, with the first of the properties now formally on More

Million-dollar garbage truck turns heads

A specially designed garbage truck capable of overcoming challenging terrain has been raising eyebrows on the world’s largest sand island. Waste management company Remondis Australia More

Wedding venue approved with road upgrade condition

A wedding venue overlooking one of the region’s major drinking-water storages has been given the green light following an application lodged last year. The Wappa More

Experiential art exhibitions challenge viewer perception

Two local artists are displaying their distinctive approaches to contemporary art in a pair of immersive showings. The concurrent exhibitions at Caloundra Regional Gallery explore More

Crime scene declared after fire

A late-night fire inside an unoccupied building is being treated as suspicious as police appeal for information and vision from the public. Police and emergency More

The University of the Sunshine Coast will lead trials for an investigational vaccine that could address three viruses, including COVID-19.UniSC Clinical Trials staff will enrol participants in a Moderna phase 1 trial, of a combination investigational vaccine for COVID-19, influenza and respiratory syncytial virus at its South Bank clinic in Brisbane.This will be the third time UniSC Clinical Trials conducts a trial for Moderna, to evaluate its mRNA technology.

Principal investigator Dr Nischal Sahai will oversee the trial that will assess the safety and immunogenicity of the investigational vaccine.Dr Sahai said the study presented the opportunity to evaluate the potential of investigational combination mRNA vaccines.“The investigational vaccine will be evaluated to see if it can help to reduce the burden of respiratory disease and offer the community the opportunity to be vaccinated for common respiratory viruses with one single dose and a yearly booster thereafter,” he said.“This is an investigational mRNA vaccine which contains acids that are naturally found in our body’s cells. We hope that it will instruct the body to make antibodies when exposed to these three respiratory viruses.”

UniSC will lead the trials. Picture: Shutterstock.

The study requires healthy volunteers between the ages of 50 and 75. Participants will be asked to attend seven clinic visits and eight phone calls over a period of up to 13 months.“The investigational vaccine will be administered by injection into the upper arm muscle, like the annual influenza vaccine,” Dr Sahai said.“It is hoped that by combining the vaccines for these three respiratory viruses there could be increased protection for older people due to the ease at which it could be accessed; much like paediatric vaccines, as well as potentially increasing compliance,” he said.Eligible participants will be paid for their time on the study. Those interested in volunteering can find more information at USC – trials. 

Like stories about Sunshine Coast people doing great things? Help us deliver more by registering for our free daily news feed. All it requires is your name and email. See SUBSCRIBE at the top of this article.

Subscribe to SCN’s free daily news email

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
[scn_go_back_button] Return Home
Share